[
    "{\"step_by_step_thinking\": \"Document 0 states that in normal clinical practice, chemotherapy significantly prolongs survival in patients with performance status of less than 2, more time being gained if there is no associated weight loss. The reluctance shown by many pneumologists toward using this treatment is not entirely justified. This suggests that the skepticism of pneumologists towards chemotherapy in treating advanced non-small cell lung carcinoma is not justified. Other documents also provide evidence supporting the use of chemotherapy in treating this condition.\", \"answer_choice\": \"B. no\"}"
]